Using immunoproteomics approach, we identified that DLD63-79 peptide derived from Leishmania major DLD, an important metabolic enzyme in the parasite, as a strong inducer of CD4+ T cell response in a mouse model of experimental cutaneous leishmaniasis [12]. The gene discussed is DLD; the disease is cutaneous leishmaniasis.